CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \<12 yea...
Phase 3
San Antonio, Texas, United States of America and 46 other locations
This 24-month study will assess the long-term safety and efficacy of liquid abrocitinib oral suspension with or without topical medications in childr...
Phase 3
San Antonio, Texas, United States of America and 38 other locations
participants (in Part A) and participants with atopic dermatitis (eczema) (in Part B). REGN20423 is a study medicine that is only used in cl...
Phase 1
San Antonio, Texas, United States of America and 4 other locations
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Phase 2
San Antonio, Texas, United States and 84 other locations
This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.
Phase 2
San Antonio, Texas, United States of America and 26 other locations
This is a first-in-human, Phase 1, double-blind, randomized, placebo-controlled, dose-escalation study evaluating ARQ-234. The study is designed to a...
Phase 1
San Antonio, Texas, United States and 4 other locations
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...
Phase 2
San Antonio, Texas, United States of America and 27 other locations
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...
Phase 4
San Antonio, Texas, United States and 71 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Phase 3
San Antonio, Texas, United States of America and 89 other locations
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...
Phase 2
San Antonio, Texas, United States of America and 88 other locations
Clinical trials
Research sites
Resources
Legal